Moolec Science SA
corporate_fare Company Profile
Moolec Science SA (NASDAQ:MLEC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 17 items for MLEC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 8/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for MLEC spans 6-K, SCHEDULE 13D.
Recent high-impact activity:
- Nasdaq Moves to Delist Moolec, Trading Suspended November 3
- Moolec CEO and CFO Resign as Joint Voluntary Liquidators Take Control
- Moolec Shareholders Approve Voluntary Winding Up; PwC Dismissed
- Shareholder Support Vanishes, Deepening Moolec's Going-Concern Crisis Amid Winding-Up Petition
- Moolec Science SA Faces Winding Up Petition Over $2.3M Legal Fee Dispute
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 5,571 shares in MLEC as of the October 15, 2026 settlement, a 97.5% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 2, 2026, 34.3% of MLEC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
MLEC files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.